Actos news from FiercePharma
NewsTakeda offers $8.8B for Millennium
Takeda Pharmaceutical is placing an $8.8 billion bet on cancer meds. The Japanese drugmaker has offered $25 per share for Millennium Pharmaceuticals, which not only makes the lucrative blood-cancer... Read more...
JAMA: Actos, Avandia risky for 65-plus
And the studies keep coming. An independent study of 159,000 older people... Read more...
5. Actos - Top 10 Warnings and Recalls
Drug: Actos 2006 sales: $3.05 billion Manufacturer: Takeda Safety concern: “black box;” heart failure Related Articles: > Takeda touts Actos as heart attack-free.
Diabetes groups warn against Avandia
American and European diabetes associations are jumping on the anti-Avandia bandwagon. In their new consensus statement on treatment protocols, the American Diabetes Association and the European... Read more...
Takeda touts Actos as heart attack-free
When is the best time to hit your opponents? When they're down, of course. And you hit them where they're most... Read more...
New Avandia warning 'a muddle'
The FDA has spoken--and GlaxoSmithKline is breathing a sigh of relief. The agency did stiffen warnings on the embattled diabetes med Avandia, but it shied away from linking the drug to heart attacks... Read more...
Avandia warning, comeback imminent?
The black-box wait is almost over. Within days, Avandia's... Read more...
Canadians warn patients against Avandia
More limits on Avandia use, this time from Canadian regulators. While the FDA continues to debate adding various warnings to GlaxoSmithKline's embattled diabetes drug, HealthCanada has induced GSK to... Read more...
ALSO NOTED: Merck vaccine prevents cervical cancer in older women; Diabetes sales drive 37 percent increase in Takeda profits;
> Gardasil protects against cervical cancer in women as old as 45, a new study shows; previously, the vaccine was only proven to work in women ages 9 to 26.
Diabetes drugs linked to fracture risk
One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women. A four-year study... Read more...
| Press ReleasesPRESS RELEASE: New Research Shows ACTOS is Associated With a 38% Lower Risk of Heart Attack in Type 2 Diabetes New Research Shows ACTOS is Associated With a 38% Lower Risk of Heart Attack in Type 2 Diabetes New research, including two studies presented this week at the 43rd Annual Meeting of the European Read more >> |
Get more Actos coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
